Correlation between Glycation-Related Biomarkers and Quality of Life in the General Japanese Population: The Iwaki Cross-Sectional Research Study

Int J Environ Res Public Health. 2022 Jul 31;19(15):9391. doi: 10.3390/ijerph19159391.

Abstract

The correlation between diabetes-related biomarkers and quality of life (QOL) remains unclear. In this cross-sectional study, we investigated the correlation between diabetes-related biomarkers and QOL in a general Japanese population who underwent health checkups as a part of the Iwaki Health Promotion Project. Male and female participants aged ≥ 20 years from Iwaki District, Hirosaki City, Aomori Prefecture who participated in the 2019 medical evaluation were recruited. QOL was evaluated using the Short Form Health Survey 36 (SF-36). Fasting blood glucose, homeostatic model assessment-estimated insulin resistance (HOMA-IR), hemoglobin A1c (HbA1c), glycoalbumin, and plasma pentosidine were also evaluated as diabetes-related markers. Of the 1065 recruited participants, 1053 completed the clinical and QOL evaluations. Multivariate regression analysis revealed that upregulated diabetes-related markers levels were correlated with decreased SF-36 scores. Blood glucose, HOMA-IR, HbA1c, glycoalbumin, and plasma pentosidine levels were correlated with general health. Moreover, plasma pentosidine levels were correlated with role physical, social functioning, and role emotional in addition to general health. These results indicated that the levels of diabetes-related biomarkers, particularly the levels of plasma pentosidine, a glycation marker, were associated with QOL in our cohort.

Keywords: HbA1c; diabetes; glycation; glycoalbumin; pentosidine; quality of life.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Blood Glucose
  • Cross-Sectional Studies
  • Diabetes Mellitus*
  • Diabetes Mellitus, Type 2*
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Insulin Resistance*
  • Japan / epidemiology
  • Male
  • Quality of Life

Substances

  • Biomarkers
  • Blood Glucose
  • Glycated Hemoglobin A

Grants and funding

This research was funded by JST’s COI program Hirosaki University Base, grant number JPMJCE1302, and FANCL Co., Inc. (Kanagawa, Japan).